Paweł Kawalec

7PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cross-sectional analysisToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 23, 2026
Association Between Dinutuximab Beta Exposure and Post-End-of-Treatment Survival in Neuroblastoma: A Weighted Patient-Level Analysis of Three Clinical Studies.

|Jun 19, 2026
European Network on Optimizing Treatment With Therapeutic Antibodies in Chronic Inflammatory Diseases: Overview, Progress and Perspectives.

|Sep 25, 2024
Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta-analysis.

Paweł Moćko, Magdalena Koperny, Katarzyna Śladowska

|Jul 06, 2022
Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries.

Przemysław Holko, Paweł Kawalec, Magdalena Sajak-Szczerba

|Jun 27, 2022
Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson's disease: a systematic review and meta-analysis.

Magdalena Żegleń, Katarzyna Śladowska, Paweł Kawalec

|Jun 17, 2022
Comparative safety of high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis.

Katarzyna Śladowska, Paweł Kawalec, Przemysław Holko

Pageof 2

Frequent Collaborators

3 joint publications

Przemysław Holko

2 joint publications

Katarzyna Śladowska

1 joint publications

Magdalena Żegleń

1 joint publications

Tomasz Brzostek